171 related articles for article (PubMed ID: 34307173)
1.
Han Y; Jiang L; Liu K; Ouyang L; Li Y
Front Oncol; 2021; 11():703949. PubMed ID: 34307173
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of HE4 in ovarian cancer: A meta-analysis.
Huang J; Chen J; Huang Q
Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():35-42. PubMed ID: 30317143
[TBL] [Abstract][Full Text] [Related]
3. Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.
Li F; Tie R; Chang K; Wang F; Deng S; Lu W; Yu L; Chen M
BMC Cancer; 2012 Jun; 12():258. PubMed ID: 22712526
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis.
Zhen S; Bian LH; Chang LL; Gao X
Mol Clin Oncol; 2014 Jul; 2(4):559-566. PubMed ID: 24940495
[TBL] [Abstract][Full Text] [Related]
5. The Diagnostic Accuracy of Serum and Urine Human Epididymis Protein 4 (HE4) in Ovarian Cancer in 15,394 Subjects: An Updated Meta-Analysis.
Nalini N; Kumar A; Sharma S; Singh B; Singh AV; Prakash J; Singh S
Cureus; 2022 Oct; 14(10):e30457. PubMed ID: 36415437
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of serum human epididymis protein 4 in ovarian cancer patients with different ethnic groups and menopausal status: a meta-analysis and systematic evaluation.
Sun R; Liu L; Feng Z; Ni A; Guo Q
Ginekol Pol; 2022 Nov; ():. PubMed ID: 36378126
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of human epididymis protein 4 compared with mesothelin for ovarian cancer: a systematic review and meta-analysis.
Lin JY; Qin JB; Li XY; Dong P; Yin BD
Asian Pac J Cancer Prev; 2012; 13(11):5427-32. PubMed ID: 23317195
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.
Suri A; Perumal V; Ammalli P; Suryan V; Bansal SK
Sci Rep; 2021 Aug; 11(1):17308. PubMed ID: 34453074
[TBL] [Abstract][Full Text] [Related]
9. Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer.
Rong Y; Li L
J Ovarian Res; 2021 Jan; 14(1):2. PubMed ID: 33397458
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic accuracy of human epididymis protein 4 (HE4) for discriminating between benign and malignant pelvic masses: a systematic review and meta-analysis.
Olsen M; Lof P; Stiekema A; van den Broek D; Wilthagen EA; Bossuyt PM; Lok CAR
Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1788-1799. PubMed ID: 34212386
[TBL] [Abstract][Full Text] [Related]
11. Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer?
Angioli R; Capriglione S; Aloisi A; Guzzo F; Luvero D; Miranda A; Damiani P; Montera R; Terranova C; Plotti F
Tumour Biol; 2014 Jul; 35(7):7009-15. PubMed ID: 24748235
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of serum human epididymis protein 4 (HE4) in ovarian carcinoma: a systematic review and meta-analysis.
Wu L; Dai ZY; Qian YH; Shi Y; Liu FJ; Yang C
Int J Gynecol Cancer; 2012 Sep; 22(7):1106-12. PubMed ID: 22854652
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of human epididymis secretory protein 4 for lung cancer: a systematic review and meta-analysis.
Yan L; Hu ZD
J Thorac Dis; 2019 Jul; 11(7):2737-2744. PubMed ID: 31463101
[TBL] [Abstract][Full Text] [Related]
14. Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study.
Plotti F; Terranova C; Guzzo F; De Cicco Nardone C; Luvero D; Bartolone M; Dionisi C; Benvenuto D; Fabris S; Ciccozzi M; Di Donato V; Panici PB; Angioli R
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33435590
[TBL] [Abstract][Full Text] [Related]
15. The Role of Human Epididymis Protein 4 in the Diagnosis and Prognosis of Diseases: An Umbrella Review of Systematic Reviews and Meta-Analyses of Observational Studies.
Sun ML; Yang ZY; Wu QJ; Li YZ; Li XY; Liu FH; Wei YF; Wen ZY; Lin B; Gong TT
Front Med (Lausanne); 2022; 9():842002. PubMed ID: 35402435
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature.
Capriglione S; Luvero D; Plotti F; Terranova C; Montera R; Scaletta G; Schirò T; Rossini G; Benedetti Panici P; Angioli R
Med Oncol; 2017 Aug; 34(9):164. PubMed ID: 28825178
[TBL] [Abstract][Full Text] [Related]
17. Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review.
Ferraro S; Braga F; Lanzoni M; Boracchi P; Biganzoli EM; Panteghini M
J Clin Pathol; 2013 Apr; 66(4):273-81. PubMed ID: 23426716
[TBL] [Abstract][Full Text] [Related]
18. Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis.
Lin J; Qin J; Sangvatanakul V
Eur J Obstet Gynecol Reprod Biol; 2013 Mar; 167(1):81-5. PubMed ID: 23228410
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of serum and tissue HE4 expression in ovarian cancer: a systematic review with meta-analysis of 90 studies.
Cao H; You D; Lan Z; Ye H; Hou M; Xi M
Expert Rev Mol Diagn; 2018 Apr; 18(4):371-383. PubMed ID: 29569984
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of HE4 in patients with ovarian cancer.
Yuan C; Li R; Yan S; Kong B
Clin Chem Lab Med; 2018 Jun; 56(7):1026-1034. PubMed ID: 29420303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
